Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026)
Repligen's (RGEN) quarterly Depreciation & Amortization (CF) came in at $19.8 million in Q1 2026, up 5.66% year-on-year from $18.7 million in Q1 2025, and down 0.95% on a QoQ basis from $20.0 million in Q4 2025.
Repligen (RGEN) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Repligen (RGEN) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $19.8 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) rose 5.66% year-over-year to $19.8 million in Q1 2026; TTM through Mar 2026 was $79.8 million, a 11.66% increase from a year earlier, with the FY2025 full-year figure at $78.7 million, up 13.02% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $19.8 million, down from $20.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for RGEN reached as high as $20.1 million in Q2 2025 and fell as low as $11.8 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $16.9 million across 5 years, with a median of $17.3 million in 2023.
- Across the five-year window, Depreciation & Amortization (CF) jumped 56.42% in 2023 and decreased 12.11% in 2024, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $14.4 million in 2022, then rose by 20.03% to $17.3 million in 2023, then increased by 6.41% to $18.4 million in 2024, then advanced by 8.62% to $20.0 million in 2025, then dropped by 0.95% to $19.8 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $19.8 million in Q1 2026, $20.0 million in Q4 2025, and $20.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 192.30 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 563.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 254.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 58.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 45.70 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 95.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 135.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 56.55 Mn |
| 10 | Repligen | 7.75 Bn | 6.77 Bn | 108.28 Mn | 19.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.76 Mn |
| Mar 31, 2026 | 19.76 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Dec 31, 2025 | 19.95 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Sep 30, 2025 | 20.01 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Jun 30, 2025 | 20.08 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Mar 31, 2025 | 18.70 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Dec 31, 2024 | 18.37 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Sep 30, 2024 | 17.42 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 16.98 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Mar 31, 2024 | 16.91 Mn |
| Dec 31, 2023 | 17.26 Mn |
| Dec 31, 2023 | 17.26 Mn |